Angina's Decline: Understanding the Drop in ER Visits and Hospitalizations
"Discover why fewer Americans are being hospitalized or visiting emergency rooms for angina, and what it means for cardiac care and prevention."
For years, preventable hospitalizations for angina—chest pain caused by reduced blood flow to the heart—have been on the decline. This trend has largely been attributed to improvements in medical guidelines, how physicians code diagnoses, and changes in healthcare reimbursement policies. But what's really behind this shift? And are emergency department (ED) visits for angina also decreasing?
A recent study dug into these questions, analyzing data from national surveys spanning from 1995 to 2010. The goal was to confirm if the decline in hospitalizations was continuing, and to see if ED visits told a similar story. By understanding these trends, we can gain valuable insights into how cardiac care is evolving and where we can improve preventative measures.
The study examined data from the National Hospital Discharge Survey (NHDS) and the National Hospital Ambulatory Medical Care Survey (NHAMCS), looking at both hospitalizations and ED visits related to angina. Researchers calculated rates, taking into account factors like age and sex, to get a clear picture of how these numbers have changed over time.
U.S. Heart Disease Statistics
The CDC’s National Center for Health Statistics Data Query System provides estimates for angina, coronary heart disease, and heart attacks, using data from the National Health Interview Survey and the National Health and Nutrition Examination Survey. In 2022, 4.9% of U.S. adults had ever been diagnosed with coronary heart disease. CDC data also report 13.0 million physician-office visits with coronary atherosclerosis and other chronic ischemic heart disease as the primary diagnosis. These indicators describe heart disease and related care, rather than angina-specific emergency visits or hospitalizations.
Care and Tracking Limitations
A U.S. study of preventable angina hospitalizations found that crude rates declined from 1995–1998 to 2007–2010 for men and women in each of three age groups: 18–44, 45–64, and 65 or older. Age- and sex-standardized rates also declined linearly over that period (P = .02). Contemporary stable-angina care emphasizes accurate diagnosis, evidence-based treatment, patient education, management of residual angina, and cardiovascular risk reduction, with reference to the 2024 ESC guidelines on chronic coronary syndromes. Clinical standards describe care through a limited set of quality statements aligned with current best evidence, while the available sources do not specify a single measurement method that captures every aspect of angina care.
How Angina Became a Heart Diagnosis
A historical account divides the development of ideas about angina into three periods; in the earliest, extending from antiquity into the late Middle Ages, descriptions resembling angina appeared without being linked to heart disease. William Heberden brought angina pectoris to the medical profession’s attention in 1772. Edward Jenner later suggested a probable association between angina and disease of the coronary arteries. The JAMA account says lifestyle measures and medical interventions introduced during the last quarter of the 20th century contributed to declining incidence and mortality from coronary heart disease and angina.
What's Driving the Decline in Angina Hospitalizations and ER Visits?
The study revealed some compelling trends. Hospitalization rates for angina have steadily decreased across all age groups (18-44, 45-64, and 65+) for both men and women between 1995-1998 and 2007-2010. Similarly, emergency department visit rates for angina also declined, particularly among individuals aged 65 and older during the same period. These findings confirm a significant shift in how angina is being managed in the United States.
- Evolving Diagnostic Practices: More sophisticated diagnostic tools, such as troponin testing and cardiac catheterization, may be leading to more precise diagnoses beyond just "angina." This means cases that might have been classified as angina in the past are now being identified as myocardial infarctions or coronary artery disease.
- Better Outpatient Management: Increased use of emergency departments (EDs) and outpatient clinics to manage acute chest pain is a factor.
- Shift in Coding: It has been hypothesized that changes in hospital ICD-9 CM coding are at play.
- Emphasis on Prevention: Experts suggest that comprehensive risk factor management is reducing the need for more invasive procedures and, in turn, hospitalizations.
Declining Emergency and Critical-Care Use
A 2025 comprehensive review of trimetazidine in cardiovascular disease reports that stable angina still carries substantial morbidity and healthcare costs in the United States, including over 1 million preventable emergency department visits and approximately 120,000 preventable hospitalizations annually. A study of five-year critical-care practice trends describes decreases in the proportion of chest-pain-center patients transferred to an ICU, alongside lower frequencies of chest pain of unknown cause and acute coronary syndrome as primary admission diagnoses. Its authors connect these concurrent findings with studies documenting declining emergency visits for angina, attributing the pattern to improved prevention, earlier identification, and more durable interventions for life-threatening ischemic heart disease that do not require an ICU visit.
Chest-Pain Visits and Ongoing Disease Burden
The study of preventable angina-related care found that preventable emergency visits for angina declined over time, even as noninjury emergency visits for chest pain increased by an average of about 55,000 per year in the United States during the preceding decade; the study characterized that increase as not statistically significant. Chest pain has multiple possible causes, and Mayo Clinic describes angina as chest pain caused by reduced blood flow to the heart muscle and associated with coronary artery disease. A separate review states that ischemic heart disease remains the leading global cause of death and lost life years among adults, notably women younger than 55, and estimates angina prevalence at 3%–4% in the UK. Together, these sources show why a decline in preventable angina visits does not by itself establish that chest-pain demand or the underlying disease burden has disappeared.
Established Treatments and Refractory Angina
For people with ischemic heart disease, angina is usually treated with anti-ischemic drugs and percutaneous or surgical coronary interventions. However, the review of alternative treatments notes that some patients continue to have attacks despite optimal medical treatment, while their coronary lesions are considered unsuitable for revascularization; these patients are described as having refractory angina. The supplied treatment overview distinguishes chronic stable angina, which may be controlled with lifestyle changes and medicines, from unstable angina, which requires prompt hospital treatment and may involve medicines or a procedure. These sources describe treatment options and persistent-care needs, but do not provide comparative outcome figures for the alternatives.
The Bigger Picture: Implications for Heart Health
This study underscores the importance of ongoing efforts to prevent and manage cardiovascular disease effectively. The decline in angina-related hospitalizations and ED visits suggests that strategies focused on early intervention, risk factor management, and improved diagnostic accuracy are making a real difference.
Personalized Decisions and Relief
A 2019 analysis of stable-angina treatment-planning conversations reports that patients can have difficulty understanding tradeoffs among treatment alternatives and examines whether inadequate health literacy acts as a barrier to communication. A 2024 expert opinion paper describes coronary revascularization, optimal medical therapy, and lifestyle interventions as complementary parts of angina management, emphasizing a personalized approach directed at the underlying pathobiology. A 2025 study set out to assess the incidence, predictors, and outcomes of complete angina relief among symptomatic patients receiving invasive management with revascularization plus optimal medical therapy or conservative management with optimal medical therapy alone. The supplied study summary describes that research question but does not report its results.
Market Forecasts and Emerging Opportunities
Industry forecasts point to expected growth in the global angina market, although the supplied excerpts give no market-size or revenue figures. 6Wresearch attributes anticipated growth to increasing cardiovascular disease prevalence, a rising older population, and healthcare technology advances. Introspective Market Research highlights potential opportunities in Asia-Pacific, Latin America, and the Middle East, alongside technologies intended to make angina management more efficient, personalized, and user-friendly. Verified Market Reports identifies demographic shifts, technological convergence, and changing healthcare policies as forces that may shape the market, including aging populations in North America, Europe, and parts of Asia-Pacific.
Living With Angina
Lorraine Kinzel, 54, from Redruth, Cornwall, has experienced angina since having a heart attack in 2013. In her account for the British Heart Foundation, she describes angina as potentially debilitating and says she has received substantial support. The World Heart Federation also states that angina negatively affects quality of life. These accounts highlight personal and daily-life impacts alongside the clinical measures used to track emergency visits and hospitalizations.
However, the researchers emphasize the need for further investigation. More comprehensive data on admission and discharge diagnoses would help clarify how angina cases are being reclassified. Additionally, a more precise definition of preventable ED visits is needed to better assess the quality of outpatient care.
Regardless of the reasons, maintaining a focus on primary and secondary prevention strategies remains crucial. By promoting healthy lifestyles, managing risk factors, and ensuring access to quality outpatient care, we can continue to reduce the burden of angina and improve heart health outcomes for all Americans.